Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

China Diagnostic Reagent Industry Report, 2010

Research In China, Oct 2010, Pages: 43


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

In 2009, China’s diagnostic reagent market represented about 5% of the global market, and Chinese enterprises still concentrated on low-end biochemistry diagnostic reagent market.

In China, there had been more than 70 biochemistry diagnostic reagent producers by the end of 2009, with sales over RMB 4 billion in total. At present, there are only about a dozen of immune diagnostic reagent producers with sales of RMB 1.5 billion in total, and there are no more than five nucleic acid diagnostic reagent producers with the market size of no more than RMB 500 million in all. By contrast, in foreign markets, the share of biochemistry diagnostic reagent has become very low, while immune diagnostic reagent and nucleic acid diagnostic reagent featuring higher detection sensitivity and specificity have become the mainstream.

The major diagnostic reagent producers in China include KHB and Da An Gene, all of which hold certain market shares by virtue of their own technology strength. Da An Gene mainly produces nucleic acid diagnostic reagent which can compete with the international advanced level in technology and quality. In 2009, Da An Gene’s nucleic acid diagnostic reagent business accounted for over 50% of the company’s operating income and about 60% of the domestic nucleic acid diagnostic reagent market. In addition, with the launch of China nucleic acid blood screening market, the nucleic acid blood screening business is expected to become a new profit point of Da An Gene.



This title is also available in the following language

China Diagnostic Reagent Industry Report, 2010 (Chinese Version)



Customers who bought this item also bought

China Diagnostic Reagent Industry Report, 2010

China Diagnostic Reagent Industry Report, 2011-2012

China Diagnostic Reagent Industry Report, 2011-2012

China Diagnostic Reagent Market Report, 2007-2009

China Diagnostic Reagent Market Report, 2007-2009

Molecular Diagnostics - Technologies, Markets and Companies

Laboratory Chemical Reagents - Global Strategic Business Report

China In Vitro Diagnostics Market Outlook to 2016

China Human Vaccine Industry Report, 2010-2011

European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds